Washington Sues DaVita and Fresenius Over Noncompete Covenants Restricting Dialysis Clinics and Care

The State of Washington filed an antitrust and consumer protection lawsuit in Thurston County Superior Court against the state’s two largest for-profit dialysis providers, DaVita Inc. and Fresenius Medical Care Holdings Inc. Attorney General Nick Brown alleges that the healthcare corporations unlawfully imposed restrictive noncompete agreements on nephrologists serving as medical directors across their facilities. The complaint asserts that these restrictive covenants suppress regional competition, block new dialysis clinics from opening, and severely limit treatment options, including home-based hemodialysis, for approximately 9,000 Washington residents suffering from end-stage renal disease. Federal Medicare rules require every operating dialysis facility to maintain a qualified nephrologist as an on-site medical director. By binding local kidney specialists to exclusive geographic covenants that frequently extend to entire nephrology practices, DaVita and Fresenius effectively prevent competing providers from securing the clinical leadership required by federal law to open rival facilities. The state contends that these contract terms violate Chapter 49.62 of the Revised Code of Washington, known as the Noncompetition Covenants Act, as well as the Consumer Protection Act, and seeks statutory penalties alongside court orders voiding the covenants across Washington.

Medicare Mandates and the Medical Director Bottleneck

Federal healthcare standards establish a direct operational link between nephrology staffing and outpatient dialysis licensing. Under Electronic Code of Federal Regulations Title 42, specifically 42 CFR Section 494.140, every dialysis facility certified to treat Medicare patients must appoint a physician medical director. The designated director must be board-certified or eligible in nephrology and bear direct legal responsibility for quality assurance, staff credentialing, and clinical infection control. Furthermore, federal rules require that the medical director possess at least twelve months of documented clinical experience providing care to patients undergoing hemodialysis or peritoneal dialysis in an approved facility. Because Medicare reimburses the vast majority of end-stage renal disease treatments nationwide, operating without Medicare certification is financially impossible for private and non-profit dialysis operators alike.

This statutory requirement transforms qualified nephrologists into the primary gateway for opening any new clinic. Washington faces a structural scarcity of licensed kidney specialists, particularly outside the Seattle and Tacoma urban cores, as fellowship graduations have failed to keep pace with chronic kidney disease prevalence. When a corporation hires a local nephrologist to oversee clinical operations on a part-time basis, attaching a geographic noncompete clause effectively locks up that physician's regulatory license. A rival provider attempting to build a regional clinic in Thurston, Kitsap, or Yakima County cannot simply recruit nursing staff and secure physical real estate; the entrant must first identify an unencumbered nephrologist willing to serve as medical director. By precluding employed and contracted medical directors from contracting with competing facilities, the dominant providers construct an insurmountable regulatory barrier to entry.

Duopoly Market Power Across Washington Counties

The commercial dialysis sector in Washington is concentrated in the hands of two publicly traded entities. According to the state's legal filing with the Washington State Office of the Attorney General, DaVita and its operating subsidiaries run 51 dialysis centers across the state. Fresenius Medical Care Holdings and its affiliates operate 29 centers. Together, these two national chains control more than 80 operational treatment centers, encompassing the overwhelming majority of licensed hemodialysis stations from the Puget Sound basin to the Idaho border.

This geographic distribution creates localized monopolies across substantial portions of Washington. In several non-metropolitan counties, only one of the two corporations maintains an operating center, leaving patients with no alternative facility within a 30-mile radius. The state's complaint details geographic concentration across rural and suburban regions, including portions of the Olympic Peninsula, Central Washington, and Southwestern Washington, where patients face travel times exceeding an hour each way if a clinic closes intake. Hemodialysis patients require blood filtration treatments three times each week, with individual sessions typically lasting between three and four hours. Because missing or delaying a session causes dangerous fluid accumulation and electrolyte imbalance, patients must accept whatever scheduling, chair availability, and nursing ratios the sole regional operator provides. The complaint alleges that DaVita and Fresenius utilized their market dominance not merely to maintain existing clinics, but to enforce covenants that prevent new entrants from contesting regional pricing and treatment schedules. The enforcement of these clauses shields low-performing centers from consumer-driven market pressure.

Statutory Standards Under Washington Noncompetition Law

Washington state maintains some of the nation's most stringent statutory boundaries regarding employee and independent contractor restrictions. In 2019, the Legislature enacted comprehensive labor reform codified in Revised Code of Washington Chapter 49.62, known as the Noncompetition Covenants Act. Under RCW 49.62.030, a noncompetition covenant entered into with an independent contractor is void and unenforceable unless the contractor's annual earnings from the contracting party exceed a statutory floor, which is adjusted annually by the Department of Labor and Industries and exceeds $250,000 for recent contract years.

The state's lawsuit asserts that the part-time medical director roles structured by DaVita and Fresenius routinely violate this statutory threshold. Most nephrologists serving as medical directors provide administrative oversight on a secondary, part-time schedule while maintaining their primary clinical medical practices. The annual stipends paid for these administrative director duties frequently fall far short of the mandatory independent contractor earnings floor. Furthermore, the complaint highlights that both corporations frequently applied these restrictive provisions to entire physician practice groups. Under these group covenants, if one partner in a private nephrology clinic agreed to direct a DaVita or Fresenius facility, the contract prohibited all other partners and associates in the practice from working with rival operators. Under RCW 49.62.080 and the Washington Consumer Protection Act, the Attorney General seeks statutory penalties of $5,000 per violation alongside civil penalties reaching up to $100,000 per corporate violation for willful anticompetitive restraint of trade.

Suppression of In-Home Hemodialysis and Technological Alternatives

The restriction of clinical leadership has directly influenced the adoption of modern home-based dialysis modalities across Washington. While traditional hemodialysis requires traveling to a commercial clinic to be connected to stationary machinery, peritoneal dialysis and home hemodialysis permit patients to undergo filtration while sleeping or during flexible home hours. Clinical studies have established that home-based therapies reduce cardiovascular strain, preserve residual kidney function longer, and eliminate exhausting travel schedules for chronically ill patients.

Despite these clinical advantages, home dialysis programs require specialized training facilities, continuous nursing support, and physician supervision. Independent health networks and regional hospital systems seeking to establish home dialysis training programs must partner with certified nephrologists to oversee patient protocols. According to the state's Thurston County Superior Court Complaint, noncompete covenants have repeatedly blocked nephrologists from assisting independent programs attempting to launch competing home-care options. Furthermore, independent clinics that offer nocturnal home hemodialysis protocols must invest in dedicated patient training staff, telehealth monitoring systems, and specialized reverse-osmosis water systems for residential installation, requiring clinical directorship that existing noncompete contracts actively barred. From a financial perspective, Medicare reimbursement models under the End-Stage Renal Disease Prospective Payment System reward clinic operators with predictable bundled facility payments for in-center chair sessions. When patients transition to home care, commercial providers forfeit facility chair fees while incurring capital expenditures for home equipment distribution. By restricting physician mobility, the companies preserved high utilization rates in their physical centers while slowing the regional transition to more flexible home care.

Corporate Defense Arguments and Federal Scrutiny

DaVita and Fresenius have defended their contractual frameworks as essential tools for preserving operational stability and clinical quality across specialized medical facilities. In public responses following the filing, DaVita representatives asserted that the state's lawsuit presents an inaccurate characterization of its medical director relationships. The company argued that medical directorships involve extensive investments in clinical governance, proprietary clinical protocols, electronic health record workflows, and patient safety monitoring that require contractual protection against commercial disruption.

DaVita also emphasized that its contractual practices have been the subject of ongoing dialogue with federal regulatory bodies, including the Federal Trade Commission, which has scrutinized labor restrictions across the national healthcare sector. Healthcare defense attorneys contend that medical director agreements represent collaborative partnerships between dialysis providers and independent physician practices rather than standard employer-worker covenants. Under this interpretation, the noncompetition provisions are designed to prevent rival corporations from free-riding on established compliance programs and staff training investments. Outpatient dialysis centers operate under strict federal life-safety and clinical quality guidelines where medical directors assume direct legal accountability for patient morbidity, mortality tracking, and water-purification testing. Establishing an effective dialysis center requires multi-million dollar investments in reverse-osmosis filtration infrastructure, emergency backup generators, and specialized bio-waste handling systems. Both corporate defendants have signaled their intention to challenge the state's statutory interpretations in court, arguing that federal Medicare mandates necessitate close, exclusive relationships between clinics and their directing nephrologists to guarantee continuous patient safety.

Regional Healthcare Ramifications for Puget Sound and Kitsap Patients

The outcome of the Thurston County litigation carries immediate consequences for kidney failure patients residing in Puget Sound communities, including Kitsap County and the broader Olympic Peninsula. Patients in Bremerton, Silverdale, and Port Orchard must coordinate dialysis schedules with transit providers, such as Kitsap Transit's routed buses and ACCESS paratransit services. Because missing scheduled transport can cause skipped treatments and emergency hospitalizations, the presence of accessible, competing facilities directly determines patient health outcomes and community transit burdens.

Transit routes connecting Bainbridge Island, Kingston, and South Kitsap often require multiple transfers, compounding the physical exhaustion endured by hemodialysis patients following intensive filtration sessions. Expanding local facility competition directly reduces the geographic burden placed on vulnerable patients and family caregivers. If the court strikes down the disputed noncompete covenants, regional health networks and community hospitals could rapidly expand specialized nephrology services. Institutions such as St. Michael Medical Center in Silverdale and independent medical groups on the Kitsap Peninsula would gain the legal freedom to contract with experienced nephrologists to direct community-based dialysis suites. Greater physician mobility would also allow non-profit community clinics to establish specialized treatment shifts tailored to working patients and maritime workers who cannot attend midday appointments. Across Kitsap County, local nephrologists balance clinic directorships with inpatient consults and outpatient referrals throughout West Sound. If regional healthcare providers can retain nephrologists without fear of corporate contract litigation, health systems could integrate outpatient dialysis directly into primary care networks, shortening transit times, lowering out-of-pocket costs, and expanding access to preventive kidney care across Western Washington.